Cargando…
Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
Autores principales: | Revés, Joana, Abreu, Bárbara S., Chaparro, María, Gisbert, Javier P., Allocca, Mariangela, Fiorino, Gionata, Barberio, Brigida, Zingone, Fabiana, Pisani, Anthea, Cassar, David, Michalopoulos, Georgios, Mantzaris, Gerassimos J., Mountaki, Katerina, Koutroubakis, Ioannis E., Karmiris, Konstantinos, Katsanos, Konstantinos, Duricova, Dana, Burisch, Johan M., Madsen, Gorm Roager, Maaser, Christian, Arebi, Naila, Orfanoudaki, Eleni, Milivojevic, Vladimir, Buisson, Anthony, Avedano, Luisa, Leone, Salvatore, Torres, Joana, Ellul, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212269/ http://dx.doi.org/10.1016/S0016-5085(22)62387-4 |
Ejemplares similares
-
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study
por: Mantzaris, Gerassimos J, et al.
Publicado: (2021) -
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022) -
Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022) -
Clinical profiles of moderate and severe Crohn’s disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines
por: Mantzaris, Gerassimos J., et al.
Publicado: (2015) -
Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study
por: Allocca, Mariangela, et al.
Publicado: (2020)